Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
BioPharma Dive
12h
Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
All aboard feared dead
Agency halts events
Signs education orders
Victims of DC plane crash
FDA upgrades recall
Ex-FDNY chief pleads guilty
Senate confirmation hearing
'The Voice' alum dies at 44
Gun trafficking indictments
Lawsuit to keep records
Bird flu 'widespread' in MA
Drops classified docs case
Jury weighs charges
Fall behind in reading
Zeldin confirmed by Senate
In talks to invest in OpenAI
Hamas frees more hostages
OpenAI probing DeepSeek
DOJ weighs dropping case?
Presidential historian dies
Witkoff meets Netanyahu
First spacewalk together
Syria’s transitional pres
US economy grew 2.3%
Agrees to settle Trump suit
Pushes for earlier trial
Plans job, output cuts in US
Gets 11 years in prison
Related topics
Daiichi Sankyo
Enhertu
Food and Drug Administration
Feedback